CVID vs X-Linked Agammaglobulinaemia MRCP Part 1

TL;DR

Immuno: B-Cell Disorders: CVID vs X-Linked Agamma is a frequently tested MRCP Part 1 topic because both conditions present with recurrent bacterial infections but differ in age of onset, genetics, B-cell numbers and associated complications. X-linked agammaglobulinaemia (XLA) is a congenital B-cell maturation defect due to BTK mutations, whereas common variable immunodeficiency (CVID) is a heterogeneous disorder characterised by impaired antibody production. Understanding the distinctions is essential for exam success and clinical practice.

Why this matters

Antibody deficiencies account for a significant proportion of primary immunodeficiency disorders encountered in examinations. Questions often present a patient with recurrent sinopulmonary infections and ask candidates to identify:

• The underlying diagnosis

• The genetic defect

• Expected immunoglobulin levels

• B-cell findings

• Long-term complications

Failure to differentiate CVID from XLA is a common reason candidates lose marks.

Core sections

The five most tested subtopics

1. Pathophysiology

X-linked Agammaglobulinaemia (Bruton's disease)

XLA is caused by mutations in the Bruton tyrosine kinase (BTK) gene located on the X chromosome.

BTK is essential for B-cell maturation. Defective signalling prevents pre-B cells from maturing into functional B lymphocytes.

Key consequences:

• Markedly reduced mature B cells

• Severe reduction in all immunoglobulin classes

• Poor antibody production

Common Variable Immunodeficiency

CVID is not a single disease but a heterogeneous group of disorders.

Patients generally have:

• Normal or near-normal B-cell numbers

• Impaired B-cell differentiation into plasma cells

• Reduced antibody production

The precise genetic cause is often unknown.

2. Age of Presentation

This distinction is highly examinable.

XLA

• Usually presents after maternal IgG wanes

• Symptoms begin around 6–12 months of age

• Primarily affects males

CVID

• Often presents later

• Adolescence or adulthood is typical

• Both sexes affected

Exam pearl: Adult-onset recurrent infections strongly favour CVID.

3. Clinical Features

Both disorders cause recurrent bacterial infections.

Common infections include:

• Otitis media

• Sinusitis

• Pneumonia

• Bronchiectasis

However, important differences exist.

Feature	XLA	CVID
Typical onset	Infancy	Adolescence/adulthood
Sex	Male predominance	Both sexes
B-cell count	Very low/absent	Usually normal
Tonsils	Small or absent	Usually present
Lymph nodes	Poorly developed	Usually present
Autoimmune disease	Less common	Common
Malignancy risk	Lower	Increased
Genetics	BTK mutation	Heterogeneous

This comparison table is one of the highest-yield revision tools for MRCP Part 1.

4. Immunological Findings

Questions frequently provide laboratory results.

XLA

Typical findings:

• Very low IgG

• Very low IgA

• Very low IgM

• Absent CD19-positive B cells

CVID

Typical findings:

• Low IgG

• Low IgA

• Sometimes low IgM

• B-cell numbers often normal

The presence of normal B-cell numbers despite hypogammaglobulinaemia should immediately suggest CVID.

5. Complications

XLA

Common complications include:

• Recurrent bacterial infections

• Chronic lung disease

• Enteroviral infections

CVID

Complications extend beyond infection.

Important associations:

• Autoimmune haemolytic anaemia

• Immune thrombocytopenia

• Coeliac-like enteropathy

• Granulomatous disease

• Non-Hodgkin lymphoma

• Gastric carcinoma

Exam pearl: Autoimmunity plus recurrent infections strongly suggests CVID.

High-Yield Revision Points

1. XLA results from BTK mutation on the X chromosome.

2. XLA causes failure of B-cell maturation.

3. XLA presents after maternal IgG disappears.

4. CVID usually presents in adolescence or adulthood.

5. B cells are absent in XLA.

6. B-cell numbers are often normal in CVID.

7. Both disorders cause recurrent encapsulated bacterial infections.

8. Small tonsils suggest XLA.

9. Autoimmune disease is strongly associated with CVID.

10. Immunoglobulin replacement is a cornerstone of management in both conditions.

Practical examples / mini-cases

Mini-Case

A 24-year-old woman reports recurrent sinus infections since university. Blood tests demonstrate low IgG and low IgA levels. Flow cytometry shows normal circulating B-cell numbers. She previously developed autoimmune thrombocytopenia.

What is the most likely diagnosis?

A. Severe combined immunodeficiencyB. X-linked agammaglobulinaemiaC. Common variable immunodeficiencyD. Chronic granulomatous diseaseE. Hyper-IgE syndrome

Answer

C. Common variable immunodeficiency

Explanation

The combination of:

• Adult presentation

• Hypogammaglobulinaemia

• Normal B-cell numbers

• Autoimmune disease

is classic for CVID.

XLA would usually present in infancy and demonstrate markedly reduced circulating B cells.

Five Common Exam Traps

Trap 1

Assuming all antibody deficiencies present in childhood.

Reality: CVID frequently presents in adulthood.

Trap 2

Confusing absent antibodies with absent B cells.

Reality: CVID patients may have normal B-cell numbers.

Trap 3

Ignoring sex distribution.

Reality: XLA is X-linked and mainly affects males.

Trap 4

Missing autoimmune manifestations.

Reality: Autoimmune disease is a major clue towards CVID.

Trap 5

Forgetting physical examination findings.

Reality: Small or absent tonsils strongly suggest XLA.

Practical Study-Tip Checklist

Use this checklist during revision:

• □ Memorise the BTK mutation association.

• □ Learn age of presentation differences.

• □ Know expected B-cell counts.

• □ Review immunoglobulin patterns.

• □ Remember autoimmune complications of CVID.

• □ Recognise absent tonsils in XLA.

• □ Practise comparison questions.

• □ Complete antibody deficiency questions in the Free MRCP MCQs section.

• □ Reinforce learning through MRCP video lectures.

• □ Test retention with regular mock examinations via Start a mock test.

Cross-Link Suggestions

After reviewing this topic, candidates should also study:

• Primary immunodeficiency disorders

• T-cell deficiencies

• Hypersensitivity reactions

• Complement deficiencies

• Vaccination in immunocompromised patients

These related subjects frequently appear alongside antibody deficiency questions in MRCP Part 1 examinations.

FAQs

What is the key difference between CVID and XLA?

XLA results from a BTK mutation causing absent mature B cells, whereas CVID usually has normal B-cell numbers but impaired antibody production.

Why does XLA present after six months of age?

Maternal IgG provides passive immunity during early infancy. Symptoms emerge once maternal antibodies decline.

Which condition is more strongly associated with autoimmune disease?

CVID. Autoimmune cytopenias and inflammatory complications are well-recognised features.

What infections are commonly seen in both disorders?

Recurrent infections caused by encapsulated bacteria, particularly affecting the ears, sinuses and lungs.

How are these conditions treated?

Treatment primarily involves immunoglobulin replacement therapy, prompt management of infections and monitoring for long-term complications.

Ready to start

Distinguishing between CVID and X-linked agammaglobulinaemia is essential for MRCP Part 1 success. Remember the key differences:

• BTK mutation and absent B cells = XLA

• Normal B cells with impaired antibody production = CVID

• Infancy presentation = XLA

• Adult presentation with autoimmunity = CVID

Mastering these distinctions will help you answer immunology questions quickly and accurately in the examination.

Continue your preparation with:

MRCP Part 1 overview

Free MRCP MCQs

Start a mock test

Sources

1. MRCP(UK) Examination Blueprint and Curriculum.

2. British Society for Immunology.

3. Abbas AK, Lichtman AH. Basic Immunology.

4. Murphy K. Janeway's Immunobiology.

5. European Society for Immunodeficiencies (ESID).

6. NHS England guidance on primary immunodeficiency disorders.